Multifunctional Prussian lue nanozymes ameliorate tendinopathy via modulating tissue homeostasis
Source abstract
Abstract
Tendinopathy, a prevalent musculoskeletal disorder characterized by chronic pain and functional decline, remains a therapeutic challenge due to the limited efficacy of conventional treatments in addressing oxidative stress and persistent inflammation. Here, we present Prussian blue nanozymes (PBzymes) as a catalytic nanomedicine engineered to mimic multi-enzyme activities, offering a potent strategy for tendon microenvironment modulation and repair. Synthesized via a hydrothermal template-free approach, PBzymes exhibit robust reactive oxygen species (ROS)-scavenging capabilities through intrinsic superoxide dismutase, catalase, and peroxidase-like activities, effectively neutralizing •OH, H 2 O 2 , and •OOH radicals. In vitro studies demonstrate PBzymes' ability to mitigate tert-butyl hydroperoxide (t-BHP)-induced oxidative damage in tenocytes and restore cell viability via ROS clearance. In a collagenase-induced rat tendinopathy model, localized PBzyme administration suppressed inflammatory tissue damage, inhibited aberrant differentiation of tendon progenitor cells and promoted collagen fiber realignment achieving a significant increase in biomechanical strength of tissue samples compared to untreated controls. Mechanistically, PBzymes attenuated MAPK signaling activation in M1 macrophages, downregulating pro-inflammatory cytokines (Interleukin-1β and Tumor Necrosis Factor-α) production while enhancing M2 reparative macrophage polarization. Histological and gait analyses of treated rat further confirmed functional recovery, with treated tendons exhibiting near-native collagen architecture and restored locomotor parameters. Comprehensive biosafety evaluations revealed no systemic toxicity that would underscore PBzymes' clinical potential. This work pioneers nanozyme-mediated tendon regeneration, bridging catalytic nanotechnology and immunomodulation to address unmet needs in musculoskeletal therapeutics.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Medical and Biological Ozone Research · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (48)
Show source-provided references
1. Tendinopathy10.1038/s41572-020-00234-1 ↗
2. Tendon injury and tendinopathy: healing and repair
3. Reactive oxygen species in tendon injury and repair10.1016/j.redox.2025.103568 ↗
4. Association of superoxide-induced oxidative stress with Rotator Cuff tears in human patients10.1002/jor.24472 ↗
5. Bone targeted nano-drug and nano-delivery10.1038/s41413-024-00356-2 ↗
6. Current research trends of nanomedicines10.1016/j.apsb.2023.05.018 ↗
7. Biomimetic materials and fabrication approaches for bone tissue engineering
8. Nanoparticle-Cartilage interaction: Pathology-Based intra-articular drug delivery for osteoarthritis therapy10.1007/s40820-021-00670-y ↗
9. The advances in nanomedicine for bone and cartilage repair10.1186/s12951-022-01342-8 ↗
10. Designing nanozymes for in vivo applications10.1038/s44222-024-00205-1 ↗
11. In situ conversion of atherosclerotic plaques' iron into nanotheranostics10.1021/jacs.4c15068 ↗
12. Copper-based nanozymes: properties and applications in biomedicine10.15541/jim20220716 ↗
13. Soluble or insoluble prussian blue for radiocesium and thallium poisoning?10.1345/aph.1E024 ↗
14. Prussian blue nanoparticle: from a photothermal conversion agent and a drug delivery System, to a bioactive drug10.1021/accountsmr.3c00260 ↗
15. Recent advances in reactive oxygen species scavenging nanomaterials for wound healing
16. Prussian blue nanozyme normalizes microenvironment to delay osteoporosis
17. Prussian blue nanozyme as a pyroptosis inhibitor alleviates neurodegeneration10.1002/adma.202106723 ↗
18. Prussian blue nanozyme promotes the survival rate of skin flaps by maintaining a normal microenvironment10.1021/acsnano.2c02832 ↗
19. Prussian blue nanozyme-mediated nanoscavenger ameliorates acute pancreatitis via inhibiting TLRs/NF-kappa B signaling pathway10.7150/thno.52010 ↗
20. Excavating bioactivities of nanozyme to remodel microenvironment for protecting chondrocytes and delaying osteoarthritis
21. Neutrophil-like cell-membrane-coated nanozyme therapy for ischemic brain damage and long-term neurological functional recovery10.1021/acsnano.0c07973 ↗
22. Restoring tendon microenvironment in tendinopathy: macrophage modulation and tendon regeneration with injectable tendon hydrogel and tendon-derived stem cells exosomes
23. Functional tendon regeneration is driven by regulatory T cells and IL-33 signaling10.1126/sciadv.adn5409 ↗
24. Leptin enhances M1 macrophage polarization and impairs tendon-bone healing in Rotator Cuff Repair: a rat model10.1097/CORR.0000000000003428 ↗
25. Polylactic acid electrospun membranes coated with chiral hierarchical-structured hydroxyapatite nanoplates promote tendon healing based on a macrophage-homeostatic modulation strategy
26. Piezoelectric nanofilms fabricated by coaxial electrospun polycaprolactone/Barium titanate promote Achilles tendon regeneration by reducing IL-17A/NF-κB-mediated inflammation
27. Comparative single-cell analysis reveals Tendon progenitor dysfunction by age-associated oxidative stress and its restoration by antioxidant treatments10.1002/jcp.70016 ↗
28. Irreversible electroporation improves Tendon healing in a rat model of collagenase-induced achilles tendinopathy10.1177/03635465231167860 ↗
29. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche10.1038/nm1630 ↗
30. Functional regeneration and repair of tendons using biomimetic scaffolds loaded with recombinant periostin10.1038/s41467-021-21545-1 ↗
31. Collagens--structure, function, and biosynthesis10.1016/j.addr.2003.08.002 ↗
32. Nonoperative or surgical treatment of acute achilles' Tendon Rupture10.1056/NEJMoa2108447 ↗
33. Characterization of scar tissue biomechanics during adult murine flexor tendon healing10.1016/j.jmbbm.2022.105192 ↗
34. Cell death10.1016/j.cell.2023.11.044 ↗
35. In vitro CO-Releasing and antioxidant properties of sulfonamide-based CAI-CORMs in a H(2)O(2)-Stimulated human Achilles Tendon-Derived cell model10.3390/molecules30030593 ↗
36. Hypoxia-Inducible factor and oxidative stress in Tendon degeneration: a molecular perspective10.3390/antiox13010086 ↗
37. The pathology of oxidative stress-induced autophagy in a chronic rotator cuff enthesis tear10.3389/fphys.2023.1222099 ↗
38. Association of recurrent tear after Arthroscopic Rotator Cuff Repair and superoxide-induced oxidative stress10.1177/03635465211014856 ↗
39. Tert-butyl hydroperoxide (t-BHP) induced apoptosis and necroptosis in endothelial cells: roles of NOX4 and mitochondrion10.1016/j.redox.2016.12.036 ↗
40. The role of the macrophage in tendinopathy and tendon healing10.1002/jor.24667 ↗
41. Macrophages in immunoregulation and therapeutics10.1038/s41392-023-01452-1 ↗
42. From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation10.3389/fimmu.2014.00514 ↗
43. Tendon stem progenitor cells: understanding the biology to inform therapeutic strategies for tendon repair10.1002/jor.24156 ↗
44. Reactive oxygen species in macrophages: sources and targets10.3389/fimmu.2021.734229 ↗
45. Prussian blue nanozyme as a pyroptosis inhibitor alleviates neurodegeneration10.1002/adma.202106723 ↗
46. Prussian blue nanozyme-mediated nanoscavenger ameliorates acute pancreatitis via inhibiting TLRs/NF-kappaB signaling pathway10.7150/thno.52010 ↗
47. Tendon Stem/Progenitor cell subpopulations and their implications in Tendon biology
48. The functions and mechanisms of Tendon Stem/Progenitor cells in Tendon healing